Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
2.575
-0.375 (-12.71%)
At close: Dec 5, 2025, 4:00 PM EST
2.680
+0.105 (4.08%)
After-hours: Dec 5, 2025, 7:27 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K